Calyx

Through innovative eClinical solutions and services, Calyx turns the uncertain into the reliable, helping bring new medical treatments to market faster. With deep expertise in clinical development and more than 25 years of supporting trial sponsors and clinical research organizations (CROs), Calyx harnesses that intelligence and activates its potential to solve complex problems, deliver fast insights, and get new drugs to market every day.

As an independent and agile company, Calyx is investing in innovative technology, serving new markets, and delivering more value to help the global bio-pharmaceutical industry bring much-needed treatments to patients, faste.

At Calyx, we are committed to shaping the future of clinical research. Backed by the industry’s brightest minds and pioneering technology, we race toward the complex for the good of our customers and their patients around the world whose lives depend on the treatments we help them develop.

With a global footprint, robust operational infrastructure, and deep scientific knowledge, Calyx solves complex clinical development challenges to help our customers bring new medical treatments to patients who need them, faster.

Calyx’s proven solutions are used in the development of new medical treatments, enabling our customers to bring lifesaving and life-improving options to patients around the world.

To date, Calyx’s solutions have been used in the clinical development of over 650 approved medical treatments.  We’re proud that over 70 of those are treatments that received Breakthrough Therapy designation and are now helping patients with serious conditions see substantial improvement, compared to other available therapies.